{
    "pmcid": "10664894",
    "qa_pairs": {
        "How do soluble antibodies targeting the receptor-binding motif (RBM) affect the SARS-CoV-2 spike protein?": [
            "They induce proteolytic processing at the S1/S2 and S2\u2019 cleavage sites, leading to ACE2-independent cell-cell fusion.",
            "They prevent the spike protein from binding to the host ACE2 receptor.",
            "They enhance the spike protein's ability to evade immune detection.",
            "They reduce the spike protein's affinity for the host cell membrane."
        ],
        "What is a potential therapeutic strategy to counteract spike-mediated cell-cell transmission resistance to neutralization?": [
            "Inhibiting S1/S2 proteolysis to re-sensitize the process to neutralization.",
            "Increasing the concentration of convalescent plasma.",
            "Enhancing the binding affinity of extracellular antibodies.",
            "Blocking the ACE2 receptor on host cells."
        ],
        "What is a suggested approach for nanobody design to maintain efficacy against emerging variants of concern (VOCs)?": [
            "Targeting conserved regions across variants.",
            "Focusing solely on the receptor-binding domain (RBD).",
            "Enhancing the spike protein's ability to bind to the ACE2 receptor.",
            "Increasing the spike protein's immune evasion capabilities."
        ],
        "What is the role of the polybasic cleavage site at the S1/S2 junction in the SARS-CoV-2 spike protein?": [
            "It is critical for spike activation and syncytia formation, facilitating virus spread.",
            "It prevents the spike protein from binding to the host ACE2 receptor.",
            "It enhances the spike protein's ability to evade immune detection.",
            "It reduces the spike protein's affinity for the host cell membrane."
        ],
        "What should be considered when designing nanobodies targeting the SARS-CoV-2 spike protein?": [
            "The role of the S1/S2 cleavage site and the potential for antibody-induced activation.",
            "The ability to enhance the spike protein's affinity for the ACE2 receptor.",
            "The potential to increase the spike protein's immune evasion capabilities.",
            "The necessity to reduce the spike protein's membrane fusion efficiency."
        ]
    }
}